ABSTRACT
In general, CPAP is considered to be the initial treatment of choice in OSAS. The current indications of CPAP may have to be revisited once the results from the longitudinal follow-up of the SHHS are made available. CPAP is safe and cost-effective (84); however, patient acceptance and compliance is less than optimal initially and compliance may decline over time. Continued improvement in technology with better mask-patient interface may help to improve compliance. Further research providing greater insights into the pathophysiology of OSAS will help in the development of more innovative modes of therapy.
